Cano Health, Inc.
CANO · NYSE
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.01 | 0.85 | -0.23 | 0.00 |
| FCF Yield | -29.24% | -3.84% | -0.96% | -2.98% |
| EV / EBITDA | -9.32 | -105.74 | -147.47 | 45.48 |
| Quality | ||||
| ROIC | -5.12% | -5.11% | 7.71% | 4.63% |
| Gross Margin | 15.40% | 12.36% | 19.87% | 21.23% |
| Cash Conversion Ratio | 0.34 | 1.10 | 0.13 | 0.78 |
| Growth | ||||
| Revenue 3-Year CAGR | 48.78% | 64.52% | 9,403,640.78% | 7,122,791.14% |
| Free Cash Flow Growth | -20.25% | -664.45% | 14.00% | 0.00% |
| Safety | ||||
| Net Debt / EBITDA | -5.93 | -18.56 | -23.91 | -1.66 |
| Interest Coverage | -1.43 | -2.00 | 1.25 | 1.06 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 1,274.07 | 722.72 | 440.67 |
| Cash Conversion Cycle | 14.50 | 9.63 | 12.88 | 50.58 |